Patents by Inventor Anett Perlberg

Anett Perlberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline Form of Pemirolast
    Publication number: 20170202839
    Abstract: There is provided a hemihydrate form of the sodium salt of pemirolast.
    Type: Application
    Filed: December 28, 2016
    Publication date: July 20, 2017
    Applicant: RSPR Pharma AB
    Inventors: Anett Perlberg, Martin Viertelhaus, Ulrika Rosenström, Karol Horvath
  • CRYSTALLINE FORM OF PEMIROLAST
    Publication number: 20160250217
    Abstract: There is provided a hemihydrate form of the sodium salt of pemirolast.
    Type: Application
    Filed: October 12, 2015
    Publication date: September 1, 2016
    Applicant: RSPR Pharma AB
    Inventors: Anett Perlberg, Martin Viertelhaus, Ulrika Rosenström, Karol Horvath
  • Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists
    Patent number: 9174985
    Abstract: The invention relates to salts of (7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid which are useful for treating diseases affected by the activation of the IP receptor, pharmaceutical compositions that contain the salts and processes for preparing the salts are also described.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: November 3, 2015
    Assignee: Novartis AG
    Inventors: Catherine Leblanc, Stephen Carl McKeown, Anett Perlberg, Nicola Tufilli
  • Methods of treating diabetes
    Patent number: 9067962
    Abstract: Solid forms of anhydrous (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol are disclosed, in addition to methods of their use in the treatment of various diseases and disorders.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: June 30, 2015
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: Susan Margaret De Paul, Anett Perlberg, Matthew Mangzhu Zhao
  • Crystalline form of pemirolast
    Patent number: 9006431
    Abstract: There is provided a hemihydrate form of the sodium salt of pemirolast.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: April 14, 2015
    Assignee: RSPR Pharma AB
    Inventors: Anett Perlberg, Martin Viertelhaus, Ulrika Rosenström, Karol Horvath
  • Salts of an IP Receptor Agonist
    Publication number: 20150011555
    Abstract: The invention relates to salts of (7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid which are useful for treating diseases affected by the activation of the IP receptor, pharmaceutical compositions that contain the salts and processes for preparing the salts are also described.
    Type: Application
    Filed: January 11, 2013
    Publication date: January 8, 2015
    Applicant: NOVARTIS AG
    Inventors: Catherine Leblanc, Stephen Carl McKeown, Anett Perlberg, Nicola Tufilli
  • New Crystalline Form of Pemirolast
    Publication number: 20140329839
    Abstract: There is provided a hemihydrate form of the sodium salt of pemirolast.
    Type: Application
    Filed: May 12, 2014
    Publication date: November 6, 2014
    Applicant: CARDOZ AB
    Inventors: Anett Perlberg, Martin Viertelhaus, Ulrika Rosenström, Karol Horvath
  • Crystalline form
    Patent number: 8809340
    Abstract: This invention relates to a new crystalline form of the succinate salt of the epithelial sodium channel (ENaC) blocker 3-(3-{2-[(E)-3,5-Diamino-6-chloro-pyrazine-2-carbonylimino]-1,3,8-triaza-spiro[4.5]decane-8-carbonyl}-benzenesulfonylamino)-propionic acid dipropylcarbamoylmethyl ester, pharmaceutical compositions comprising said crystalline form, uses of said crystalline form and pharmaceutical compositions, and methods for preparing said crystalline form.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: August 19, 2014
    Assignee: Novartis AG
    Inventors: Catherine Howsham, Christian Lindenberg, Anett Perlberg, Nicola Tufilli
  • Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use
    Patent number: 8653094
    Abstract: Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate and salts thereof are disclosed.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: February 18, 2014
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: Mark S. Bednarz, Susan De Paul, Ramanaiah C. Kanamarlapudi, Anett Perlberg, Haiming Zhang
  • NOVEL CRYSTALLINE FORM
    Publication number: 20130345239
    Abstract: This invention relates to a new crystalline form of the succinate salt of the epithelial sodium channel (ENaC) blocker 3-(3-{2-[(E)-3,5-Diamino-6-chloro-pyrazine-2-carbonylimino]-1,3,8-triaza-spiro[4.5]decane-8-carbonyl}-benzenesulfonylamino)-propionic acid dipropylcarbamoylmethyl ester, pharmaceutical compositions comprising said crystalline form, uses of said crystalline form and pharmaceutical compositions, and methods for preparing said crystalline form.
    Type: Application
    Filed: March 12, 2013
    Publication date: December 26, 2013
    Inventors: Catherine Howsham, Christian Lindenberg, Anett Perlberg, Nicola Tufilli
  • METHODS OF TREATING DIABETES
    Publication number: 20130165395
    Abstract: Solid forms of anhydrous (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol are disclosed, in addition to methods of their use in the treatment of various diseases and disorders.
    Type: Application
    Filed: June 22, 2012
    Publication date: June 27, 2013
    Inventors: Susan Margaret De PAUL, Anett PERLBERG, Matthew Mangzhu ZHAO
  • SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE
    Publication number: 20130005754
    Abstract: Solid forms of (S)-ethyl 2-amino-3 -(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate and salts thereof are disclosed.
    Type: Application
    Filed: June 1, 2012
    Publication date: January 3, 2013
    Inventors: Mark S. BEDNARZ, Susan De PAUL, Ramanaiah C. KANAMARLAPUDI, Anett PERLBERG, Haiming ZHANG
  • Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use
    Patent number: 8217156
    Abstract: Solid forms of anhydrous (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol are disclosed, in addition to methods of their use in the treatment of various diseases and disorders.
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: July 10, 2012
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: Susan Margaret De Paul, Anett Perlberg, Matthew Mangzhu Zhao
  • New Crystalline Form of Pemirolast
    Publication number: 20120157415
    Abstract: There is provided a hemihydrate form of the sodium salt of pemirolast.
    Type: Application
    Filed: June 15, 2010
    Publication date: June 21, 2012
    Applicant: CARDOZ AB
    Inventors: Anett Perlberg, Martin Viertelhaus, Ulrika Rosentrôm, Karol Horvath
  • Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use
    Patent number: 8193204
    Abstract: Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate and salts thereof are disclosed.
    Type: Grant
    Filed: September 25, 2008
    Date of Patent: June 5, 2012
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: Mark S. Bednarz, Susan De Paul, Ramanaiah C. Kanamarlapudi, Anett Perlberg, Haiming Zhang
  • SOLID FORMS OF (2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL AND METHODS OF THEIR USE
    Publication number: 20100016422
    Abstract: Solid forms of anhydrous (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol are disclosed, in addition to methods of their use in the treatment of various diseases and disorders.
    Type: Application
    Filed: July 15, 2009
    Publication date: January 21, 2010
    Inventors: Susan Margaret De Paul, Anett Perlberg, Matthew Mangzhu Zhao
  • SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE
    Publication number: 20090088447
    Abstract: Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate and salts thereof are disclosed.
    Type: Application
    Filed: September 25, 2008
    Publication date: April 2, 2009
    Inventors: Mark S. Bednarz, Susan De Paul, Ramanaiah C. Kanamarlapudi, Anett Perlberg, Haiming Zhang